where can i buy compounded tirzepatide You4You 1 and GIP therapy Tirzepatide Injection - The Pharmacy

Tirzepatide additionally activates the GIP receptor a dual mechanism that produces superior weight loss outcomes in head-to-head trials

Background Based on unprecedented demand and Eli Lillys inability to meet this demand, the tirzepatide products at issue, Mounjaro and Zepbound, whose marketing applications were approved in 2022 and 2023 respectively, were placed on the drug shortage list in December 2022

Its counterpart, Zepbound, contains the same active ingredient and is FDA-approved for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related issue, such as high blood pressure or obstructive sleep apnea

The worst-case scenario is not treating obesity at all and experiencing progressive metabolic deterioration, cardiovascular disease, diabetes, and reduced quality of life over decades

This question arises as tirzepatide gains attention for its metabolic benefits in type 2 diabetes and weight management